We are live on ! Find out more
PLC

Peapod Lane Capital Portfolio holdings

AUM $148M
1-Year Est. Return 89.92%
This Fund
S&P 500
This Quarter Est. Return
+27.69%
1 Year Est. Return
+89.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$148M
AUM Growth
+$26.3M
Cap. Flow
+$6.69M
Cap. Flow %
4.52%
Top 10 Hldgs %
32.18%
Holding
69
New
7
Increased
42
Reduced
12
Closed
8

Top Buys

Rank Stock Value
1
ENGN icon
enGene Therapeutics
ENGN
+$4.49M
2
PCYO icon
Pure Cycle
PCYO
+$2.04M
3
BCYC
Bicycle Therapeutics
BCYC
+$1.91M
4
BSET icon
Bassett Furniture
BSET
+$1.84M
5
FULC icon
Fulcrum Therapeutics
FULC
+$1.74M

Top Sells

Rank Stock Value
1
CVGI icon
Commercial Vehicle Group
CVGI
+$2.28M
2
FDMT icon
4D Molecular Therapeutics
FDMT
+$2.21M
3
FONR
Fonar
FONR
+$2.11M
4
TWIN icon
Twin Disc
TWIN
+$1.62M
5
KVHI icon
KVH Industries
KVHI
+$1.58M

Sector Composition

Rank Sector Weight
1 Industrials 21.12%
2 Healthcare 19.35%
3 Consumer Discretionary 16.44%
4 Real Estate 9.39%
5 Consumer Staples 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGP icon
26
Resources Connection
RGP
$146M
$2.28M 1.54%
536,955
+8,544
+2% +$35.9K
BCYC
27
Bicycle Therapeutics
BCYC
$294M
$2.28M 1.54%
537,978
+416,872
+344% +$1.91M
LAKE icon
28
Lakeland Industries
LAKE
$117M
$2.22M 1.5%
207,657
+79,539
+62% +$803K
UEIC icon
29
Universal Electronics
UEIC
$58.2M
$2.21M 1.49%
462,801
+7,310
+2% +$30.4K
BSET icon
30
Bassett Furniture
BSET
$162M
$2.19M 1.48%
+123,868
New +$1.84M
NNDM
31
Nano Dimension
NNDM
$333M
$2.11M 1.42%
1,451,728
-308,815
-18% -$504K
SGOV icon
32
iShares 0-3 Month Treasury Bond ETF
SGOV
$104B
$2.1M 1.42%
20,900
+899
+4% +$90.4K
CVGI icon
33
Commercial Vehicle Group
CVGI
$127M
$2.04M 1.37%
440,663
-486,867
-52% -$2.28M
ARQ icon
34
Arq
ARQ
$94.3M
$2.01M 1.36%
787,880
+12,531
+2% +$31.1K
PCYO icon
35
Pure Cycle
PCYO
$275M
$2M 1.35%
+186,734
New +$2.04M
LAB icon
36
Standard BioTools
LAB
$252M
$1.98M 1.34%
2,411,474
+382,947
+19% +$362K
ENGN icon
37
enGene Therapeutics
ENGN
$122M
$1.91M 1.29%
+1,102,149
New +$4.49M
SGA icon
38
Saga Communications
SGA
$56.6M
$1.9M 1.28%
209,865
+3,313
+2% +$33.9K
FTEK icon
39
Fuel Tech
FTEK
$46.2M
$1.81M 1.22%
820,592
+341,750
+71% +$507K
INGN icon
40
Inogen
INGN
$146M
$1.69M 1.14%
262,775
+4,130
+2% +$27.3K
HYNE
41
Hoyne Bancorp
HYNE
$134M
$1.64M 1.11%
98,232
+1,544
+2% +$24.6K
NKTX icon
42
Nkarta
NKTX
$198M
$1.56M 1.05%
549,923
-126,289
-19% -$356K
WHG icon
43
Westwood Holdings Group
WHG
$189M
$1.54M 1.04%
80,120
+1,261
+2% +$21.2K
IPI icon
44
Intrepid Potash
IPI
$506M
$1.51M 1.02%
46,173
+87
+0.2% +$3.31K
NTIC icon
45
Northern Technologies International Corp
NTIC
$77.2M
$1.51M 1.02%
176,114
+33,472
+23% +$270K
ALTO icon
46
Alto Ingredients
ALTO
$316M
$1.5M 1.01%
263,383
-143,002
-35% -$730K
MYPS icon
47
PLAYSTUDIOS Inc
MYPS
$60M
$1.5M 1.01%
+3,002,579
New +$1.44M
PLRX icon
48
Pliant Therapeutics
PLRX
$68.7M
$1.49M 1.01%
1,309,013
+20,435
+2% +$24.9K
INVE icon
49
Identive
INVE
$66.9M
$1.48M 1%
587,212
+210,482
+56% +$845K
OM icon
50
Outset Medical
OM
$74.1M
$1.43M 0.97%
+331,951
New +$1.45M
1
2
3

Similar funds

VIS
Vertex Investment Solutions Chiyoda-Ku $148M AUM
SA
Sacks & Associates Warren, New Jersey $148M AUM
NCM
Nitor Capital Management Englewood Cliffs, New Jersey $148M AUM
PSB
Piscataqua Savings Bank Portsmouth, New Hampshire $148M AUM 32.61% 1-Year Est. Return
PPWM
Perissos Private Wealth Management Bethany, Oklahoma $148M AUM 24.7% 1-Year Est. Return
AAG
Accordant Advisory Group Annapolis, Maryland $148M AUM 23.8% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $148M AUM
MCM
Moon Capital Management New York $148M AUM 25.37% 1-Year Est. Return

Peapod Lane Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Peapod Lane Capital held 69 positions worth $148M, up 22% from $122M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Peapod Lane Capital deployed $6.69M of net new capital in Q2 2026, opening 7 new positions and adding to 42 existing holdings. Its largest new stake was enGene Therapeutics: 1,102,149 shares worth $1.91M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Commercial Vehicle Group, an estimated $2.28M trimmed.

  • Peapod Lane Capital's largest Q2 2026 buy was enGene Therapeutics: 1,102,149 shares worth $1.91M.
  • Peapod Lane Capital added most to Bicycle Therapeutics in Q2 2026, an estimated $1.91M increase.
  • Peapod Lane Capital's biggest Q2 2026 reduction was Commercial Vehicle Group, cutting an estimated $2.28M.
  • Peapod Lane Capital fully exited 4D Molecular Therapeutics in Q2 2026, selling an estimated $2.21M.
  • Peapod Lane Capital's ten largest holdings make up 32% of its $148M portfolio in Q2 2026.
  • Peapod Lane Capital opened 7 new positions and closed 8 in Q2 2026.
  • Peapod Lane Capital's portfolio value rose 22% quarter-over-quarter to $148M.

Based on Peapod Lane Capital's 13F filing for Q2 2026, filed 27 Jul 2026.